Pharma . Management

Pharma . Management reported total assets of 249,343 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).

Company number (CBE) 0439.966.462 · VAT BE0439966462
4000 Liège
active in Buying and selling of own real estate (NACE 6811002)
operating since 08 Jan 1990 (≈ 36 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pharma . Management shows with a free account.

See the score
Profile
since 1990
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−1,362 €
Equity190,957 €
EBITDA−1,362 €
Total assets249,343 €
The line marks its sector median: 18.4% (2666 companies).

Change 2022 → 2025: Equity -1 % Total assets -1 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pharma . Management's annual accounts

20252024202320222021
Net result−1,362 €
Equity190,957 €
EBITDA−1,362 €
Total assets249,343 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jul 2026
  • Year ended 31 Dec 2024filed on 07 Nov 2025
  • Year ended 31 Dec 2023filed on 23 Oct 2024
  • Year ended 31 Dec 2022filed on 26 Oct 2023
  • Year ended 31 Dec 2021filed on 12 Aug 2022

Pharma . Management's financial analysis

Management and control of Pharma . Management

2 active director(s) in the register.

Pharma . Management's shareholders and holdings →

Pharma . Management's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0439.966.462
VAT number
BE0439966462
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Incorporated
08 Jan 1990
Registered office
4000 Liège
Latest accounts
2025 · filed on 29 Jul 2026
Activity
Buying and selling of own real estate (NACE 6811002)

Pharma . Management has been based in Liège since 1990, active in: buying and selling of own real estate. For 2025, it reports a net loss of 1,362 € and equity of 190,957 €; its revenue is not published. Its solvency stands at 76.6%, above the median of its sector (18.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Pharma . Management

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pharma . Management

What is the revenue of Pharma . Management?

Pharma . Management files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Pharma . Management?

In Belgium, the VAT number is the company number prefixed with BE: BE0439966462 for Pharma . Management, if the company is VAT-registered. Its company number (CBE) is 0439.966.462.

Where is the registered office of Pharma . Management?

According to the CBE register, the registered office of Pharma . Management is in 4000 Liège.

What is the equity of Pharma . Management?

At the close of the 2025 financial year, the equity of Pharma . Management amounts to 190,957 €, a solvency of 76.6% of total assets.

Who manages Pharma . Management?

The register lists 2 active mandates at Pharma . Management. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Pharma . Management

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 31 Jul 2026

No credit card, no commitment.

What each plan unlocks →